Unichem Laboratories Limited (BOM: 506690)

Unichem Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	1,509	1,838	1,092	774.61	2,315
Short-Term Investments	-	-	-	2,260	-	-
Trading Asset Securities	-	13.39	15.36	376.28	2,364	4,191
Cash & Short-Term Investments	1,523	1,523	1,853	3,728	3,139	6,506
Cash Growth	-18.54%	-17.83%	-50.30%	18.76%	-51.76%	-34.79%
Accounts Receivable	-	6,104	5,886	4,954	2,503	3,901
Other Receivables	-	136.88	96.35	135.5	428.35	456.18
Receivables	-	6,241	5,983	5,090	2,931	4,358
Inventory	-	7,127	6,288	6,083	5,548	4,191
Prepaid Expenses	-	206.61	234.32	210.48	189.98	182.19
Other Current Assets	-	1,878	1,561	1,372	1,965	1,627
Total Current Assets	-	16,975	15,919	16,484	13,773	16,865
Property, Plant & Equipment	-	13,171	14,026	14,823	14,464	11,950
Long-Term Investments	-	0.2	1.61	2.85	1,556	1,308
Goodwill	-	15.45	15.45	15.45	15.45	15.45
Long-Term Deferred Tax Assets	-	67.75	101.13	43.55	139.54	29.38
Other Long-Term Assets	-	1,462	1,867	1,818	1,309	1,279
Total Assets	-	31,693	31,930	33,188	31,257	31,447
Accounts Payable	-	2,994	2,907	1,832	2,101	2,502
Accrued Expenses	-	2,047	699.37	555.94	523.02	507.17
Short-Term Debt	-	1,553	2,081	2,157	1,006	1,840
Current Portion of Long-Term Debt	-	256.63	256.63	256.63	-	-
Current Portion of Leases	-	42.12	51.6	42.18	41.58	40.21
Current Income Taxes Payable	-	22.07	4.91	20.95	32.61	6.31
Current Unearned Revenue	-	76.93	245.27	269.49	282.88	100.89
Other Current Liabilities	-	88.07	150.56	387.32	1,070	670.2
Total Current Liabilities	-	7,079	6,396	5,521	5,058	5,667
Long-Term Debt	-	382.22	636.49	890.11	-	-
Long-Term Leases	-	241.53	114.93	145.71	143.1	184.54
Long-Term Deferred Tax Liabilities	-	-	-	-	137.02	-
Other Long-Term Liabilities	-	280.49	294.95	317.72	290.11	255.39
Total Liabilities	-	8,069	7,577	7,004	5,689	6,134
Common Stock	-	140.81	140.81	140.81	140.81	140.81
Additional Paid-In Capital	-	13.3	13.3	13.3	13.3	13.3
Retained Earnings	-	23,391	23,975	25,061	25,012	24,950
Comprensive Income & Other	-	79.31	223.87	969.19	402.42	209.21
Shareholders' Equity	23,624	23,624	24,353	26,184	25,568	25,314
Total Liabilities & Equity	-	31,693	31,930	33,188	31,257	31,447
Total Debt	2,475	2,475	3,140	3,492	1,191	2,065
Net Cash (Debt)	-952.63	-952.63	-1,288	236.25	1,948	4,441
Net Cash Growth	-	-	-	-87.87%	-56.14%	-44.36%
Net Cash Per Share	-13.71	-13.53	-18.29	3.35	27.67	63.08
Filing Date Shares Outstanding	70.65	70.41	70.41	70.41	70.41	70.41
Total Common Shares Outstanding	70.65	70.41	70.41	70.41	70.41	70.41
Working Capital	-	9,896	9,523	10,963	8,716	11,197
Book Value Per Share	335.54	335.54	345.90	371.90	363.16	359.54
Tangible Book Value	23,609	23,609	24,338	26,169	25,553	25,298
Tangible Book Value Per Share	335.32	335.32	345.68	371.68	362.94	359.32
Land	-	37.8	37.8	37.8	37.8	56.78
Buildings	-	5,108	5,101	3,872	3,417	3,259
Machinery	-	11,904	11,587	9,123	7,842	7,082
Construction In Progress	-	1,227	1,475	4,938	5,675	3,305

Source: S&P Capital IQ. Standard template. Financial Sources.